Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 282 participants.
Also called NCT01115738
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 282 participants
- Sponsor
- Registry
-
NCT01115738 -
CTRI/2010/091/000348
-
- Other papers using this trial's data
- Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial
- Transferring from clopidogrel loading dose to prasugrel loading dose in acute coronary syndrome patients. High on-treatment platelet reactivity analysis of the TRIPLET trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- India
- Registry status
- Completed
Technical summary
Registry record NCT01115738. Randomized; double masking; primary purpose treatment. Start 2010-05 (registry gives no type); primary completion 2011-11 (actual). Results posted on 2012-10-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clopidogrel to Prasugrel in Acute Coronary Syndrome (ACS) Patients
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01115738- Content hash
77cde066e0a6a191327e51bbdabcd6e3e572748ae58587dc57345ff2426751dd